Results 181 to 190 of about 716,992 (304)

Protocol to induce memory generalization and stress-like behaviors without memory strengthening using contextual fear conditioning in mice. [PDF]

STAR Protoc
Cheng X, Zhao Y, Hu Y, Lin WJ, Ye X.
europepmc   +1 more source

Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS‐CoV‐2 infection (Neuro‐PASC) between females and males. Methods Cross‐sectional study of the first consecutive 261 posthospitalization Neuro‐PASC (PNP) and 2068 nonhospitalized Neuro‐PASC (NNP) patients evaluated at the Neuro‐COVID clinic between ...
Hannah Kopinsky, Melissa Lopez, Janet Miller, Millenia Jimenez, Eric M. Liotta, Igor J. Koralnik   +5 more
wiley   +1 more source

Region- and cell type-specific changes in gene expression in the cerebellum after classical fear conditioning. [PDF]

Commun Biol
Ji J, Baek J, Hwang KD, Choi S, Kasuya J, Roh SE, Kim SJ, Abel T, An JY, Lee YS.   +9 more
europepmc   +1 more source

Behavioral and genetic architecture of fear conditioning and related phenotypes. [PDF]

Neurobiol Learn Mem, 2023
Zeid D, Seemiller LR, Wagstaff DA, Gould TJ.   +3 more
europepmc   +1 more source

A twin study of the genetics of fear conditioning

, 2003
Fear conditioning is a traditional model for the acquisition of fears and phobias. Studies of the genetic architecture of fear conditioning may inform gene-finding strategies for anxiety disorders. The objective of this study was to determine the genetic
Annas, Peter, Fredrikson, Mats,, Hettema, John M, Neale, Michael C, Kendler, Kenneth S   +4 more
core  

Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias, Federica Avantaggiato, Gianni Pezzoli, Andrea Canessa   +3 more
wiley   +1 more source

Psychophysiological Outcome Responses in Human Pavlovian Fear Conditioning: A Prediction Error Analysis. [PDF]

Psychophysiology
Liu H, Linnell J, Bach DR.
europepmc   +1 more source

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto, Dariia Kliushnikova, Richard Friedrich Radlberger, Sinan Yasaroglu, Tobias Moser, Andrea Harrer, Kitty Kratzer, Wolfgang Hitzl, Christiane Gradl, Martin Schmidauer, Patrick Roth, Harald Hegen, Peter Wipfler   +12 more
wiley   +1 more source

Computational protocol for hierarchical Bayesian modeling of perception and generalization in fear conditioning. [PDF]

STAR Protoc
Yu K, Vanpaemel W, Tuerlinckx F, Zaman J.   +3 more
europepmc   +1 more source

Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali, Priyanka Menon, Halil I. Corbali, Ram Jagannathan, Allan I. Levey   +4 more
wiley   +1 more source